Protara Therapeutics Q3 EPS $(0.35) Beats $(0.37) Estimate
Benzinga Newsdesk 1 hour ago
NewsEarningsEarnings Beats
Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.37) by 5.41 percent. This is a 12.9 percent decrease over losses of $(0.31) per share
Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.37) by 5.41 percent. This is a 12.9 percent decrease over losses of $(0.31) per share from the same period last year.